GPT-5 and Automated Lab Reduce Cell-Free Protein Synthesis Costs by 40%

GPT-5 and Automated Lab Reduce Cell-Free Protein Synthesis Costs by 40%

According to OpenAI, an autonomous laboratory system combining GPT-5 with Ginkgo Bioworks’ cloud automation platform has successfully reduced the cost of cell-free protein synthesis by 40%. The breakthrough was achieved through closed-loop experimentation, where the AI system iteratively designed and executed experiments without human intervention.

Cell-free protein synthesis is a biotechnology method that produces proteins outside of living cells, offering advantages in speed and flexibility for research and pharmaceutical applications. The cost reduction represents a significant advancement in making this technology more accessible for various applications.

The collaboration between OpenAI’s latest language model and Ginkgo Bioworks’ automated laboratory infrastructure demonstrates how AI can optimize complex biological processes. The closed-loop approach allowed the system to learn from experimental results and continuously refine protocols to achieve greater efficiency.

This development highlights the expanding role of advanced AI models beyond text generation and into practical scientific applications, particularly in biotechnology and laboratory automation where iterative optimization can yield substantial improvements in efficiency and cost-effectiveness.